Oracle's AI Spending Outpaces Cash Flow, but Wall Street Sees Long-Term Upside

What happened

Oracle's stock has plunged 59% from its high as its massive AI infrastructure spending has outpaced cash flow, prompting a credit downgrade from S&P Global. Despite the decline, Wall Street remains bullish, citing 121% cloud infrastructure growth and a $664 billion backlog, as highlighted by a Motley Fool article. However, DeepValue's master report underscores that FY2026 free cash flow was -$23.7 billion, with only about 12% of the backlog expected to convert to revenue within 12 months. Oracle plans to raise $40 billion in FY2027, including a $20 billion at-the-market equity offering, which could dilute existing shareholders. The stock's current valuation still prices in successful execution of the AI buildout, but the market has begun to focus on the financing strain rather than just top-line growth.

Implication

The credit downgrade and negative free cash flow indicate that Oracle's aggressive AI expansion is not yet self-funding, and equity issuance could erode per-share value. While the $664B backlog and 121% cloud growth are impressive, only a small fraction of that backlog is expected to convert to revenue in the near term, delaying cash flow benefits. Until Oracle demonstrates faster monetization of its AI capacity or significantly increases customer prepayments, the risk-reward remains unattractive at current prices. The market's recent focus on the cost of financing the buildout, rather than the demand story, suggests that the stock may stay range-bound or drift lower if execution slips. Therefore, investors should wait for evidence of improved cash conversion, such as rising customer prepayments or a reduction in capex intensity, before adding positions.

Thesis delta

The article does not change the core thesis: Oracle faces a cash conversion gap that has not been resolved. The credit downgrade reinforces the view that leverage risk is rising, and until the company shows evidence of faster backlog monetization or stronger customer funding, the investment case remains a wait rather than a buy. No material shift from the previous WAIT rating.